Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?

por Copsel, Sabrina N., Wolf, Dietlinde, Pfeiffer, Brent, Barreras, Henry, Perez, Victor L., Levy, Robert B.
Publicado 2022

Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection

por Lightbourn, Casey O., Wolf, Dietlinde, Copsel, Sabrina N., Wang, Ying, Pfeiffer, Brent J., Barreras, Henry, Bader, Cameron S., Komanduri, Krishna V., Perez, Victor L., Levy, Robert B.
Publicado 2021

Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease

por Levy, Robert B., Mousa, Hazem M., Lightbourn, Casey O., Shiuey, Eric J., Latoni, David, Duffort, Stephanie, Flynn, Ryan, Du, Jing, Barreras, Henry, Zaiken, Michael, Paz, Katelyn, Blazar, Bruce R., Perez, Victor L.
Publicado 2021

BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT

por Copsel, Sabrina N., Lightbourn, Casey O., Barreras, Henry, Lohse, Ines, Wolf, Dietlinde, Bader, Cameron S., Manov, John, Kale, Brandon J., Shah, Devangi, Brothers, Shaun P., Perez, Victor L., Komanduri, Krishna V., Wahlestedt, Claes, Levy, Robert B.
Publicado 2019